- ECO Animal Health said Monday it had entered a development and licensing deal with Agrinnovation and Yissum Research Development Company of the Hebrew University of Jerusalem.

The deal, based on a number of milestone payments, would enable ECO to licence patented research related innovations, leading to the development of a long acting injectable florfenicol product to treat swine bacterial respiratory disease with a single dose, ECO said.

Florfenicol, an antimicrobial used only in veterinary medicine, and the product would complement both the spectrum of activity and the oral route of administration of Aivlosin, ECO’s patented molecule for the treatment of economically important diseases in pigs and poultry, the company added.

'Recent market research has indicated that treatment for respiratory disease accounts for over 40% of antimicrobial treatments in finishing pigs. We are delighted to have entered this collaboration with Agrinnovation,' said Peter Lawrence, Non-executive Chairman of ECO Animal Health Group said.

At 8:36am: [LON:ECO] Eco Atlantic Oil Gas Ltd share price was +1.2p at 46.7p

Story provided by